OPK241220P1000
- 0.05
- 0.000.00%
Opko Health Newsroom
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
Express News | NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results
Phillip Frost Buys Handful Of Shares In OPKO Health
Results: OPKO Health, Inc. Confounded Analyst Expectations With A Surprise Profit
OPKO Health Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Opko Health Insider Bought Shares Worth $421,535, According to a Recent SEC Filing
OPKO Health Analyst Ratings
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
Barrington Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $2.25
H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
Opko Health (OPK) Q3 2024 Earnings Call Transcript
OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript Summary
OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript
Here's What Key Metrics Tell Us About OPKO Health (OPK) Q3 Earnings
OPKO Health: Q3 Earnings Snapshot
Opko Health | 10-Q: Q3 2024 Earnings Report
Opko Health | 8-K: OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results
OPKO Health GAAP EPS of $0.03 Beats by $0.12, Revenue of $173.6M Misses by $7.93M
Express News | OPKO Health Q3 Basic EPS USD 0.04 Vs. IBES Estimate USD -0.09
Express News | OPKO Health Q3 Net Income USD 24.9 Million